Aclarion, Inc.

ACON·NasdaqCM
Compare
2.2450−0.0950 (−4.06%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2.3400
Open2.3410
Day range2.22002.3500
52-week range1.95009.7750
Off day high−4.47%
Off 52-week high−77.03%
Volume26.97K
Avg. volume (3M)51.72K
Market cap6.47M
EPS (TTM)-7.38
Forward P/E-0.41
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding2.88M
Short interest—
Earnings date—
Analyst target—
Profit margin—

Against its peers

Compare in full ›
ACON TEM BRTX TNON SCNX ICCM
Market cap 6.47M 12.27B 2.42M 8.01M 6.42M 5.01M
P/E (TTM) — — — — — —
Forward P/E -0.4 -1,190.7 -0.2 -0.2 — -0.3
Price/book 0.3 27.5 0.7 -0.2 0.1 0.3
Dividend yield — — — — — —
1-year change −74.92% −24.92% −94.57% −91.30% −79.11% −95.66%
Today −4.06% −4.14% −6.42% −12.61% +3.99% −1.82%

The closest companies by business and industry (Health Information Services). Prices may be delayed up to 15 min.

Latest news

All ACON news ›
TradingView·Negative

Price to book forward of Aclarion, Inc. – NASDAQ:ACONW

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in…

Markets Daily·Positive

Contrasting Veeva Systems (NYSE:VEEV) & Aclarion (NASDAQ:ACON)

Posted by Sarita Garza on Oct 4th, 2026 Aclarion (NASDAQ:ACON – Get Free Report) and Veeva Systems (NYSE:VEEV – Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on…

From articles in the 4Search news index.

In the news

2mentions in 30 days
2with it in the headline
Mixedsentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.